Navigation Links
VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
Date:12/14/2010

rent expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; uncertainties of patent protection and litigation; uncertainties of government or third party payer reimbursement; reliance on sole source suppliers; limited sales and marketing efforts and dependence upon third parties; risks related to the development of innovative products; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that future clinical studies discussed in this press release will be completed or successful or that any product will receive regulatory approval for any indication or prove to be commercially successful. VIVUS does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ended December 31, 2009 and periodic reports filed with the Securities and Exchange Commission.


'/>"/>
SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIVUS to Present at Two Upcoming Investor Conferences
2. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
3. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
4. VIVUS Announces Sale of MUSE Assets to Meda
5. VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
6. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
7. VIVUS to Present at Lazard Capital Markets Healthcare Conference
8. VIVUS Announces Promotion of Peter Tam to President
9. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
10. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
11. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015  Rosa & Co. LLC, a drug development ... today announced its pleasure to be lead partner for ... Systems Pharmacology (QSP). The conference focuses on uses and ... Logo - ... Rosa,s lead sponsorship is the second of ...
(Date:4/28/2015)... , April 28, 2015  BioDelivery Sciences International, ... Sarah DeRossett , MD, PhD to the position ... Affairs.  Dr. DeRossett joins BDSI with nearly twenty-five ... the neurosciences area.  Dr. DeRossett will oversee clinical ... well as the medical support for BDSI,s currently ...
(Date:4/27/2015)... China , April 27, 2015 Techpool Bio-Pharma ... under the leadership of its new chief executive officer, transforming ... Before Henry Lee took office in ... in the pharmaceutical field, including Novartis and Eisai, with more ... China and the Asia-Pacific ...
Breaking Medicine Technology:Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 2Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 3BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs 2BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs 3BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs 4Techpool Transforms Into International Player 2Techpool Transforms Into International Player 3
... Jan. 3, 2012 Reportlinker.com announces that ... in its catalogue: Transdermal ... http://www.reportlinker.com/p0203552/Transdermal-Drug-Delivery---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... -Up-to-date one-stop information on transdermal ...
... 3, 2012  When the FDA removed Fen-Phen from the U.S. ... that powerful diet pills had become a thing of the ... burners sprung up almost immediately, and it wasn,t long before ... bags and medicine cabinets. Demand for these ...
Cached Medicine Technology:Transdermal Drug Delivery - Technologies, Markets, and Companies 2Transdermal Drug Delivery - Technologies, Markets, and Companies 3Transdermal Drug Delivery - Technologies, Markets, and Companies 4Transdermal Drug Delivery - Technologies, Markets, and Companies 5Transdermal Drug Delivery - Technologies, Markets, and Companies 6Transdermal Drug Delivery - Technologies, Markets, and Companies 7Transdermal Drug Delivery - Technologies, Markets, and Companies 8Transdermal Drug Delivery - Technologies, Markets, and Companies 9Transdermal Drug Delivery - Technologies, Markets, and Companies 10Transdermal Drug Delivery - Technologies, Markets, and Companies 11BiphedAdrene™, Complex Phenylethylamine Provisional Plus Aggressive Thermogenic Compound, Leads Super-Powerful "Diet Pill" Comeback 2
(Date:4/28/2015)... China (PRWEB) April 28, 2015 Georgia ... major municipalities in China that will partner with the ... reduce smoking in a nation that produces more tobacco ... world. , The project, China Tobacco Control Partnership-Tobacco Free ... leaders have shown willingness to support tobacco control efforts ...
(Date:4/28/2015)... Missouri (PRWEB) April 28, 2015 ... to healthcare executive search, announced today that it has ... & Chief Operating Officer search for The ... , Reporting to QHS President & CEO Arthur ... Officer will have operating responsibility for the Queen’s Medical ...
(Date:4/28/2015)... April 28, 2015 Georgia Partnership ... establishment of telemedicine programs in communities throughout Georgia, announces ... selected as speakers at the American Telemedicine Association ... 2015, in Los Angeles, CA. , GPT’s roster ... Sherrie Williams, Executive Director; Loren Nix, Liaison; and board ...
(Date:4/28/2015)... April 28, 2015 Researchers from four ... dose of a steroid prior to pemetrexed (Alimta) chemotherapy ... reaction. Click here to read the full story ... from the Raabe College of Pharmacy in Ohio, Stanford ... Appalachian Regional Healthcare in Kentucky gave a single dose ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Dead or damaged ... and their property. In many cases, tree removal by a ... way to eliminate the threat. , In their ... of tree removal available to property owners today. Each method ... for a job well done. , The article states that, ...
Breaking Medicine News(10 mins):Health News:Georgia State Names Partner Cities For Tobacco Control Project 2Health News:The Queen’s Health Systems Retains MSA Executive Search to Recruit Executive Vice President & Chief Operating Officer 2Health News:Georgia Partnership for TeleHealth Team Selected to Present at ATA 2015 2Health News:Study Finds New Regimen May Ward Off Skin Rash from Common Mesothelioma Drug, According to Surviving Mesothelioma 2Health News:Tree Removal Methods and Services Discussed in Recent Article by Precision Tree Services 2
... Crestor worked well in those with normal LDL but ... 9 (HealthDay News) -- A widely used cholesterol-lowering drug ... adverse outcomes in people who do not ... Crestor (rosuvastatin), did have high levels of C-reactive protein ...
... LAFAYETTE HILL, Pa., Nov. 9 The NHS Human,Services ... on November,8, 2008 at the Hyatt Regency Penn,s Landing ... for the Foundation, which supports the mission,of NHS Human ... human,services in the country., Every year the Foundation ...
... time to change their Medicare Part D Prescription Drug Coverage begins November ... they so choose, this time period is also an opportunity for people ... , ... Washington (PRWEB) November 9, 2008 -- The National Council on Aging ...
... Glaucoma-related highlights of today,s scientific program of the 2008 ... and European Society of Ophthalmology (SOE) include a study ... carotid artery narrowing and potentially elevated risk for stroke, ... of fasting, common to the world,s seven major religions, ...
... a risk factor for high blood pressure, low levels ... as high levels of sodiumespecially among African Americans, according ... Nephrology,s 41st Annual Meeting and Scientific Exposition in Philadelphia, ... about lowering salt or sodium in the diet in ...
... patients in need of organ transplants on the rise, ... sources for organs. Individuals are willing to donate their ... the poverty rate is high, resulting in numerous reports ... troubling issue will be the topic of a session ...
Cached Medicine News:Health News:Statin Might Help More People Fight Heart Disease Than Thought 2Health News:Statin Might Help More People Fight Heart Disease Than Thought 3Health News:Gala Raises Funds for NHS Human Services 2Health News:Attention Seniors: Plans Change. Your Needs Change. Shop and Compare Your Prescription Drug Coverage Now 2Health News:Attention Seniors: Plans Change. Your Needs Change. Shop and Compare Your Prescription Drug Coverage Now 3Health News:Attention Seniors: Plans Change. Your Needs Change. Shop and Compare Your Prescription Drug Coverage Now 4Health News:AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights 2Health News:AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights 3Health News:AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights 4Health News:Low potassium linked to high blood pressure 2Health News:Transplant experts convene at ASN Renal Week 2008 to discuss organ trafficking 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: